Clinical Trials Directory

Trials / Completed

CompletedNCT06451380

Patient-controlled Sedation With Propofol Versus Anesthesiologist-administered Sedation for Orthopedic Surgery

Patient-controlled Sedation With Propofol Versus Anesthesiologist-administered Sedation for Orthopedic Surgery Under Regional Anesthesia : a Prospective Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare patient satisfaction with patient-controlled sedation with propofol and anesthesiologist-controlled sedation during orthopedic procedures of the upper limb under locoregional anesthesia.

Detailed description

This is an interventional, prospective, randomized, open-label, controlled, single-center study designed to evaluate the less commonly used patient-controlled sedation, comparing it with sedation administered by the anesthesiologist in a population of patients indicated for orthopedic upper limb surgery requiring additional sedation. Once informed consent has been signed, patients will be randomized into one of two study arms in a 1:1 ratio, stratified by age: * Experimental arm (1) : patient-controlled propofol sedation ; * Control arm (2) : anesthesiologist-controlled propofol sedation. Patient participation in the study lasts from 1 to 7 days maximum (from preoperative inclusion to hospital discharge).

Conditions

Interventions

TypeNameDescription
PROCEDUREorthopaedic surgeryorthopaedic surgery of the upper limb under anaesthesia
DRUGpropofol anesthesiaThe initial dose of propofol and the refractory period will be determined according to a standardized protocol used in current practice.

Timeline

Start date
2024-10-02
Primary completion
2025-01-09
Completion
2025-01-09
First posted
2024-06-11
Last updated
2025-11-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06451380. Inclusion in this directory is not an endorsement.